🇺🇸 Losartan and hydrochlorothiazide in United States

2,169 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 298 reports (13.74%)
  2. Drug Ineffective — 283 reports (13.05%)
  3. Nausea — 253 reports (11.66%)
  4. Diarrhoea — 249 reports (11.48%)
  5. Headache — 192 reports (8.85%)
  6. Pain — 192 reports (8.85%)
  7. Dizziness — 186 reports (8.58%)
  8. Off Label Use — 183 reports (8.44%)
  9. Dyspnoea — 180 reports (8.3%)
  10. Arthralgia — 153 reports (7.05%)

Source database →

Losartan and hydrochlorothiazide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Losartan and hydrochlorothiazide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Losartan and hydrochlorothiazide in United States?

University of Cambridge is the originator. The local marketing authorisation holder may differ — check the official source linked above.